Full-Time

Junior/Assistant Associate Manufacturing

Confirmed live in the last 24 hours

Deadline 5/31/25
Pfizer

Pfizer

10,001+ employees

Develops and manufactures biopharmaceutical products

No salary listed

Junior, Mid

Visakhapatnam, Andhra Pradesh, India

Category
Diagnostics & Laboratory Professionals
Medical, Clinical & Veterinary
Requirements
  • High School Diploma or Bsc
  • 1 to 6 years of experience
  • Strong oral and written communication skills
  • Proficiency in current Good Manufacturing Practices (cGMPs)
  • Experience in pharmaceutical manufacturing or a related field
  • Ability to troubleshoot and resolve technical issues
  • Strong organizational skills and attention to detail
  • Capability to work independently and as part of a team
  • Proficiency in using standard office software and manufacturing systems
Responsibilities
  • Operate production equipment such as Injectable , Sterile , Parenteral machines, Vial / Ampoule filling , Capping , Compounding , Washing ,Sealing, Terminal sterilization, Stopper process & Visual inspection.
  • Monitor and control the production process to ensure quality products are produced within specified parameters.
  • Maintain accurate records of production data and perform routine maintenance tasks on equipment as required.
  • Collaborate with other team members to resolve issues and improve overall efficiency.
  • Ensure adherence to Good Manufacturing Practices (GMP) guidelines.
  • Must have experience with USFDA regulatory environment & process.
Desired Qualifications
  • A Bachelor's Degree
  • Experience with Lean Manufacturing principles
  • Knowledge of regulatory requirements and quality standards
  • Familiarity with Pfizer's Learning Solution and Quality Tracking System
  • Ability to adapt to changing priorities and manage multiple tasks
  • Ability to train and mentor less-experienced colleagues

Pfizer develops and manufactures healthcare products, focusing on medicines and vaccines. The company conducts extensive research and development to create innovative treatments, which are then sold to governments, healthcare providers, and patients around the world. Pfizer's products include vaccines, oncology treatments, and specialized medicines. A key aspect of Pfizer's work is its partnership with BioNTech to produce a vaccine for COVID-19, showcasing its role in addressing public health challenges. Unlike many competitors, Pfizer emphasizes not only the development of new treatments but also initiatives to ensure access to vaccines for underserved populations. The company's goal is to expand its portfolio with new treatments while maintaining a commitment to improving global health.

Company Size

10,001+

Company Stage

IPO

Headquarters

New York City, New York

Founded

1849

Simplify Jobs

Simplify's Take

What believers are saying

  • Activist investor Starboard Value's $1B stake may drive strategic changes and increase value.
  • Pfizer's investment in Enara Bio strengthens its position in the immunotherapy market.
  • Backing Promise Bio aligns with Pfizer's strategy to enhance its precision medicine portfolio.

What critics are saying

  • Emerging biotech companies like Trimtech and Normunity could impact Pfizer's market share.
  • Slowdown in COVID-19 vaccine demand poses potential revenue challenges for Pfizer.
  • Activist investor involvement may pressure Pfizer to alter business strategies.

What makes Pfizer unique

  • Pfizer's partnership with BioNTech led to a highly effective COVID-19 vaccine.
  • Pfizer invests in AI disease models, enhancing R&D capabilities and drug discovery.
  • Pfizer's focus on precision medicine diversifies its therapeutic areas and strengthens its portfolio.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Retirement Plan

401(k) Company Match

Paid Vacation

Paid Sick Leave

Paid Holidays

Hybrid Work Options

Relocation Assistance

Company News

Finsmes
Mar 5th, 2025
Trimtech Therapeutics Raises $31M in Seed Funding

Trimtech Therapeutics, a Cambridge, UK-based biotech company harnessing targeted protein degradation (TPD) for the treatment of neurodegenerative diseases, raised $31M in Seed funding

Business Wire
Jan 16th, 2025
Normunity Closes $75 Million Series B Financing to Advance Lead Drug Program Into the Clinic and Broaden Pipeline of Novel Anti-Cancer Therapies Targeting Untapped Drug Mechanisms

Normunity, a biotechnology company creating novel anti-cancer therapies, today announced that it has closed a Series B financing for $75 million. The

TechCrunch
Oct 23rd, 2024
Promise Bio exits stealth backed by Pfizer and AstraZeneca | TechCrunch

The company has made it easier to test for different protein modifications which are critical to the treatment of autoimmune diseases.

The Wall Street Journal
Oct 7th, 2024
Exclusive | Activist Starboard Value Takes $1 Billion Stake in Pfizer

The drugmaker’s shares have slumped as demand for Covid-19 vaccines and treatments had slowed.

Benzinga
Oct 3rd, 2024
Enara Bio raises $32.5 million Series B financing to advance first-in-class pipeline of TCR-based immunotherapies targeting novel Dark Antigens®

New investors Pfizer Ventures and M Ventures co-led the financing, with participation from all existing investors including RA Capital, Samsara BioCapital and SV Health InvestorsEnara Bio's EDAPT® platform is